Citadel Advisors’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.27M Sell
195,944
-868,322
-82% -$10.1M ﹤0.01% 2575
2025
Q1
$9.29M Sell
1,064,266
-942,092
-47% -$8.22M ﹤0.01% 1299
2024
Q4
$28.8M Sell
2,006,358
-773,612
-28% -$11.1M 0.01% 767
2024
Q3
$62.8M Buy
2,779,970
+2,445,577
+731% +$55.2M 0.01% 396
2024
Q2
$6.5M Buy
334,393
+247,234
+284% +$4.81M ﹤0.01% 1487
2024
Q1
$3.27M Sell
87,159
-27,066
-24% -$1.02M ﹤0.01% 2080
2023
Q4
$6.39M Buy
114,225
+98,920
+646% +$5.54M ﹤0.01% 1502
2023
Q3
$631K Sell
15,305
-706,265
-98% -$29.1M ﹤0.01% 3508
2023
Q2
$40.3M Sell
721,570
-508,557
-41% -$28.4M 0.01% 498
2023
Q1
$68.6M Sell
1,230,127
-233,774
-16% -$13M 0.02% 335
2022
Q4
$53.3M Buy
1,463,901
+1,108,820
+312% +$40.4M 0.01% 413
2022
Q3
$10.1M Buy
355,081
+222,348
+168% +$6.33M ﹤0.01% 1273
2022
Q2
$6.01M Buy
+132,733
New +$6.01M ﹤0.01% 1696
2022
Q1
Sell
-5,616
Closed -$837K 7131
2021
Q4
$837K Sell
5,616
-59,506
-91% -$8.87M ﹤0.01% 4025
2021
Q3
$9.48M Sell
65,122
-10,108
-13% -$1.47M ﹤0.01% 1494
2021
Q2
$14.7M Buy
75,230
+72,604
+2,765% +$14.2M ﹤0.01% 1166
2021
Q1
$475K Sell
2,626
-203,255
-99% -$36.8M ﹤0.01% 4620
2020
Q4
$29.2M Buy
205,881
+89,316
+77% +$12.6M 0.01% 668
2020
Q3
$14.5M Buy
116,565
+114,008
+4,459% +$14.2M ﹤0.01% 904
2020
Q2
$228K Sell
2,557
-25,504
-91% -$2.27M ﹤0.01% 3989
2020
Q1
$1.75M Buy
28,061
+4,443
+19% +$277K ﹤0.01% 2342
2019
Q4
$1.8M Sell
23,618
-81,852
-78% -$6.24M ﹤0.01% 2462
2019
Q3
$5.32M Buy
+105,470
New +$5.32M ﹤0.01% 1617